<DOC>
	<DOC>NCT00548678</DOC>
	<brief_summary>This study will assess platelet function and safety in healthy male volunteers following doses of intravenous diclofenac compared to oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.</brief_summary>
	<brief_title>Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers</brief_title>
	<detailed_description>The primary objective is to evaluate platelet function following intravenous diclofenac, oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Healthy male subjects. Willing and able to stay at the clinical site for approximately 8 nights over 9 days and to return to the clinic approximately 7 days after discharge. Bleeding abnormalities or cardiovascular events. Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>diclofenac, platelet aggregation, ketorolac, aspirin</keyword>
</DOC>